This 2017 analysis of the Women's Health Initiative (WHI) randomized trials examined the long-term effects of menopausal hormone therapy (HT) on mortality. Among 27,347 postmenopausal women followed for a median of 18 years, neither estrogen-alone nor estrogen-plus-progestin therapy was associated with increased all-cause or cause-specific mortality, including deaths from cardiovascular
